np event 2254995 0E193A 1
Oct 7, 2024
- Oct 6, 2025
Clinical Trial Data Review for PBC Therapeutics, Including Dual Peroxisome Activated Receptor (PPAR) Alpha/Delta Agonists
0.5

Claim your AMA PRA Category 1 Credit(s), CNE Contact Hour(s) or CPE Contact Hour(s) (CEUs) credit

Already have an Account? Log In
Don’t have an account? Register Today

Pre-Test

Complete the pre-quiz poll to access the course episodes. 

Prequiz Podcast Clinical Trial Data Review for PBC Therapeutics, Including Dual Peroxisome Activated Receptor

course Faculty

Jones
Professor David Jones, OBE
Kremer
Andreas Kremer, MD, PhD
Younossi e1727102738253
Zobair Younossi, MD

Related Courses

Group 39553
Dermatology
Revisiting the Safety Record of IL-17 Inhibitors: A Guide for Dermatologists
np document 888746 0E193A 5
Rheumatology
The Evolving Science of Tyrosine Kinase 2 (TYK2) Inhibitors to Improve Outcomes in Patient...
np document 888746 0E193A 5
Neurology
Novel Therapeutic Approaches to Multiple Sclerosis: BTK and Second-Generation Anti-CD40 Th...